首页> 外文期刊>Asian Journal of Pharmaceutical Sciences >Auricularia auricular polysaccharide-low molecular weight chitosan polyelectrolyte complex nanoparticles: Preparation and characterization
【24h】

Auricularia auricular polysaccharide-low molecular weight chitosan polyelectrolyte complex nanoparticles: Preparation and characterization

机译:耳木耳多糖-低分子量壳聚糖聚电解质复合物纳米粒子的制备与表征

获取原文
           

摘要

Abstract Novel polyelectrolyte complex nanoparticles (AAP/LCS NPs) were prepared in this study and these were produced by mixing negatively charged auricularia auricular polysaccharide (AAP) with positively charged low molecular weight chitosan (LCS) in an aqueous medium. The {AAP} was extracted and purified from auricularia auricular, and then characterized by micrOTOF-Q mass spectrometry, UV/Vis spectrophotometry, moisture analyzer and SEM. The yield, moisture, and total sugar content of the {AAP} were 4.5%, 6.2% and 90.12% (w/w), respectively. The {AAP} sample was water-soluble and exhibited white flocculence. The characteristics of AAP/LCS NPs, such as the particle size, zeta potential, morphology, FT-IR spectra, {DSC} were investigated. The results obtained revealed that the AAP/LCS {NPs} had a spherical shape with a diameter of 223?nm and a smooth surface, and the results of the FT-IR spectra and {DSC} investigations indicated that there was an electrostatic interaction between the two polyelectrolyte polymers. Bovine serum albumin (BSA, pI?=?4.8) and bovine hemoglobin (BHb, pI?=?6.8) were used as model drugs to investigate the loading and release features of the AAP/LCS NPs. The results obtained showed that the AAP/LCS {NPs} had a higher entrapment efficiency (92.6%) for {BHb} than for {BSA} (81.5%). The cumulative release of {BSA} and {BHb} from AAP/LCS {NPs} after 24 h in vitro was 95.4% and 91.9%, respectively. The in vitro release demonstrated that AAP/LCS {NPs} provided a sustained release matrix suitable for the delivery of protein drugs. These studies demonstrate that AAP/LCS {NPs} have a very promising potential as a delivery system for protein drugs.
机译:摘要本研究制备了新型的聚电解质复合纳米粒子(AAP / LCS NPs),其是在水介质中将带负电荷的耳廓耳多糖(AAP)与带正电荷的低分子量壳聚糖(LCS)混合而成。 {AAP}是从耳廓耳中提取和纯化的,然后用micrOTOF-Q质谱,UV / Vis分光光度法,水分分析仪和SEM进行表征。 {AAP}的产量,水分和总糖含量分别为4.5%,6.2%和90.12%(w / w)。 {AAP}样品是水溶性的,并显示白色絮凝。研究了AAP / LCS NPs的粒径,ζ电势,形貌,FT-IR光谱,{DSC}等特性。获得的结果表明,AAP / LCS {NPs}具有直径为223?nm的球形且表面光滑,并且FT-IR光谱和{DSC}研究的结果表明,AAP / LCS {NPs}之间存在静电相互作用。两种聚电解质聚合物。牛血清白蛋白(BSA,pIα=?4.8)和牛血红蛋白(BHb,pIα=?6.8)被用作模型药物,以研究AAP / LCS NP的负载和释放特性。获得的结果表明,AAP / LCS {NPs}对{BHb}的包封效率(92.6%)比对{BSA}的包封效率(81.5%)高。体外培养24小时后,来自AAP / LCS {NPs}的{BSA}和{BHb}的累积释放分别为95.4%和91.9%。体外释放表明,AAP / LCS {NPs}提供了适用于蛋白质药物输送的持续释放基质。这些研究表明,AAP / LCS {NPs}作为蛋白药物的递送系统具有非常有前途的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号